Press Releases

Novel approach can reveal better breast cancer treatmentsYesterday
Researchers have developed a new way to approach breast cancer treatment by seeking to neutralize specific biological growth drivers.
New genetic risk factors identify two distinct glioma subtypesMar 27, 2017
Researchers led by Dr. Melissa Bondy have conducted the largest study to date of malignant brain tumors looking for genetic markers of glioma, a highly aggressive form of brain cancer.
Cancer center outreach group to host colorectal cancer playMar 24, 2017
In observation of National Colorectal Cancer Awareness Month, Baylor College of Medicine will host a play that will help educate African-Americans about the importance of preventing colorectal cancer.
Childhood cancer survivor support expanding for TexansMar 22, 2017
A recent $1.5 million grant will expand the Passport for Care program, which ensuring that childhood cancer survivors in Texas receive healthcare that meets their unique needs.
Gene ABL1 implicated in cancer, developmental disorderMar 13, 2017
Researchers link ABL1, a human gene well-known for its association with cancer, to a developmental disorder. 
Baylor’s Office of Outreach and Health Disparities collaborates with Vietnamese television to raise cancer awarenessMar 2, 2017
Baylor's Office of Outreach and Health Disparities, part of the Dan L Duncan Comprehensive Cancer Center, has launched a collaboration with VIETV to generate awareness about colorectal cancer in one of Houston’s largest demographics.
Pediatric hematology-oncology initiative launched in AfricaFeb 21, 2017
Global HOPE will build long-term capacity to treat and improve the prognosis of thousands of children with blood disorders and cancer in southern and east Africa.
Gala to raise funds for phase 1 cancer trials unitFeb 16, 2017
The annual Partnership Gala will benefit the Dan L Duncan Comprehensive Cancer Center and honor the work and career of its director, Dr. C Kent Osborne.
Scalp cooling effective in reducing hair loss during chemoFeb 14, 2017
Dr. Julie Nangia reports the results of her research studying the effectiveness of scalp cooling therapy in reducing hair loss in women undergoing chemotherapy.
Researcher contributes to project to help cancer diagnosisJan 26, 2017
An international research group including Baylor College of Medicine has received a Catalyst Award to investigate ways of bringing new and improved cancer diagnostic tests to primary care practitioners.
Study shows link between Hepatitis C virus, multiple cancersJan 26, 2017
Dr. Jennifer Kramer and colleagues examine the link between HCV and other cancers within the U.S. elderly population.
'Listening' to single cells may uncover cancer originsJan 17, 2017
Baylor scientists have developed a method that allows them to accurately determine the genes expressed in single cells.
Baylor, nation’s cancer centers endorse updated HPV vaccine recommendationsJan 11, 2017
Baylor and the other 69 National Cancer Institute-designated cancer centers endorsed recently revised recommendations from the CDC on the need to improve vaccination rates for HPV.
Breast cancer researchers receive $900,000 to support study of treatment resistance, drug efficacyDec 28, 2016
Dr. Meghashyam Kavuri and Dr. Xi Chen have been awarded grants from the Susan G. Komen Foundation to support their breast cancer research.
Mesothelioma Treatment Center opens study of new treatmentDec 20, 2016
The Mesothelioma Treatment Center has begun enrolling patients in a clinical research study for patients with malignant pleural mesothelioma.
Scalp-cooling device cuts hair loss in breast cancer patients undergoing chemotherapyDec 9, 2016
A scalp cooling cap has been shown to effective in reducing hair loss in breast cancer patients undergoing chemotherapy.
Promising results shown from combination therapy in HER2-positive and hormone receptor-positive metastatic or local advanced breast cancerDec 8, 2016
A new study reveals the efficacy and safety of treating HER2-positive and hormone receptor-positive metastatic or local advanced breast cancer with pertuzumab in combination with trastuzumab, along with an aromatase inhibitor.
NSABP B52 trial shows estrogen deprivation in neoadjuvant chemotherapy breast cancer treatment is not antagonistic to pathologic complete responseDec 8, 2016
Research by Dr. Mothaffar F. Rimawi he finds that adding an aromatase inhibitor to presurgery breast cancer treatment did not significantly increase or decrease the percentage of patients who experienced a pathologic complete response.
Disturbing circadian rhythm connected to higher risk of liver cancer in mice; link to humansNov 23, 2016
A team of researchers says disrupting a regular sleep routine can trigger the development of liver cancer in mice.
CPRIT awards Baylor College of Medicine additional $7 million to individual investigatorsNov 21, 2016
Researchers at Baylor College of Medicine have received over $7 million from the Cancer Prevention and Research Institute of Texas (CPRIT) for seven new grants.